Pharmacophore Modeling, Synthesis, and Antibacterial Evaluation of Chalcones and Derivatives

A series of novel chalcone and thiol-Michael addition analogues was synthesized and tested against Mycobacterium tuberculosis and other clinically significant bacterial pathogens. Previously reported chalcone-like antibacterials (1a–c and 2) were used as a training set to generate a pharmacophore model. The chalcone derivative hit compound 3 was subsequently identified through a pharmacophore-based virtual screen of the Specs library of >200 000 compounds. Among the newly synthesized chalcones and thiol-Michael addition analogues, chalcones 6r and 6s were active (minimum inhibitory concentrations (MICs) = 1.56–6.25 μg/mL) against Gram-positive pathogens Bacillus anthracis and Staphylococcus aureus [methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA)]. The chalcone thiol-Michael addition derivatives 7j–m showed good to excellent antibacterial activities (MICs = 0.78–6.25 μg/mL) against Enterococcus faecalis, B. anthracis, and S. aureus. Interestingly, the amine-Michael addition analogue 12a showed promising anti-MRSA activity (MIC = 1.56 μg/mL) with a selectivity index of 14 toward mammalian Vero cells. In addition, evaluation of selected compounds against biofilm and planktonic S. aureus (MSSA and MRSA) revealed that 12a exhibited bactericidal activities in these assays, which was overall superior to vancomycin. These properties may result from the compounds dissipating the proton motive force of bacterial membranes.

• Publication year

  2018

• Venue

  ACS Omega

• Publication date

  2018-12-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acsomega.8b03174PMID 30613820PMCID 6312637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?

  2019cited by this paper
• Antimicrobial resistance: A global emerging threat to public health systems

  2017cited by this paper
• OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.

  2016cited by this paper
• New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

  2016cited by this paper
• Methods for in vitro evaluating antimicrobial activity: A review☆

  2015cited by this paper
• Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile

  2015cited by this paper
• Synthesis, Structure–Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and Derivatives

  2014cited by this paper
• QSAR and docking studies on chalcone derivatives for antitubercular activity against M. tuberculosis H37Rv

  2014cited by this paper
• Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin.

  2014cited by this paper
• National burden of invasive methicillin-resistant Staphylococcus aureus infection.

  2014cited by this paper
• Chemical Modulation of the Biological Activity of Reutericyclin: a Membrane-Active Antibiotic from Lactobacillus reuteri

  2014cited by this paper
• Spectinamides: A New Class of Semisynthetic Anti-Tuberculosis Agents that Overcome Native Drug Efflux

  2014cited by this paper
• Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus.

  2013cited by this paper
• Eco-friendly synthesis and in vitro antibacterial activities of some novel chalcones

  2013cited by this paper
• Synthesis and antibacterial and antifungal evaluation of some chalcone based sulfones and bisulfones.

  2013cited by this paper
• National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.

  2013cited by this paper
• Evaluation of Flavonoid and Resveratrol Chemical Libraries Reveals Abyssinone II as a Promising Antibacterial Lead

  2012cited by this paper
• Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

  2010cited by this paper
• XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.

  2010cited by this paper
• Evaluation of Analogs of Reutericyclin as Prospective Candidates for Treatment of Staphylococcal Skin Infections

  2009cited by this paper
• Synthesis and Antimicrobial Activity of SomeNovel Benzimidazolyl Chalcones

  2009cited by this paper
• The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.

  2008cited by this paper
• Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem

  2007cited by this paper
• Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.

  2006cited by this paper
• Multidrug-resistance efflux pumps ? not just for resistance

  2006cited by this paper
• PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

  2006cited by this paper
• PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching

  2006cited by this paper
• Resistance to antibiotics: are we in the post-antibiotic era?

  2005cited by this paper
• Evolution and spread of antibiotic resistance

  2002cited by this paper
• Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains.

  2000cited by this paper

• Decoding the Benzaldehyde Pharmacophore: Structural Determinants for Enhancing Antibacterial Efficacy and Food Safety

  2026cites this paper
• Coumarinyl‐Thiazole Hybrids as Broad Spectrum Biologically Active Agents and Their Sustained Delivery Through Cellulose Acetate Nanofiber Mat

  2025cites this paper
• Expanding antimicrobial chemotypes: indole-based DNA gyrase inhibitors with potential dual mechanism against multidrug-resistant bacteria.

  2025cites this paper
• Chalcones as Emerging Antibacterial Scaffolds: A Mini Review.

  2025cites this paper
• Identification of druggable binding sites and small molecules as modulators of TMC1

  2025cites this paper
• Identification of Druggable Binding Sites and Small Molecules as Modulators of TMC1

  2024cites this paper
• Development of novel indole-quinoline hybrid molecules targeting bacterial proton motive force.

  2024cites this paper
• The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials

  2024cites this paper
• Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.

  2023cites this paper
• Chalcone Derivatives as Antibacterial Agents: An Updated Overview.

  2023cites this paper
• Advances in computational frameworks in the fight against TB: The way forward

  2023cites this paper
• Tetrandrine Derivatives as Promising Antibacterial Agents

  2023cites this paper
• Molecular dynamics simulation approach of hybrid chalcone–thiazole complex derivatives for DNA gyrase B inhibition: lead generation

  2023cites this paper
• A review on Millepachine and its derivatives as potential multitarget anticancer agents.

  2023cites this paper
• In vitro and in silico antibacterial evaluation of nitrocatechol chalcone and pyrazoline derivatives

  2023cites this paper
• Antibacterial and antibiotic modifying activity of chalcone (2E)-1-(4'-aminophenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps: In vitro and in silico approaches.

  2022cites this paper
• Antibacterial potential of chalcones and its derivatives against Staphylococcus aureus

  2022cites this paper
• Comprehensive insight into anti-staphylococcal and anti-enterococcal action of brominated and chlorinated pyrazine-based chalcones

  2022cites this paper
• Thiazole–Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation

  2021cites this paper
• Antitubercular and antioxidant activities of hydroxy and chloro substituted chalcone analogues: Synthesis, biological and computational studies

  2021cites this paper
• Escaping ESKAPE: A Chalcone Perspective

  2021cites this paper
• Chalcones: Synthetic Chemistry Follows Where Nature Leads

  2021cites this paper
• Synthesis of Chalcone‐Derived Heteroaromatics with Antibacterial Activities

  2020cites this paper
• Design, synthesis, and evaluation of amphiphilic sofalcone derivatives as potent Gram-positive antibacterial agents.

  2020cites this paper
• A novel chalcone derivative exerts anti-inflammatory and anti-oxidant effects after acute lung injury

  2019cites this paper
• Recent developments of chalcones as potential antibacterial agents in medicinal chemistry.

  2019cites this paper